300238 logo

Guanhao Biotech Co.,Ltd. Stock Price

SZSE:300238 Community·CN¥2.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300238 Share Price Performance

CN¥0
-15.15 (-100.00%)
CN¥0
-15.15 (-100.00%)
Price CN¥0

300238 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with questionable track record.

1 Risk
0 Rewards

Guanhao Biotech Co.,Ltd. Key Details

CN¥386.4m

Revenue

CN¥90.6m

Cost of Revenue

CN¥295.8m

Gross Profit

CN¥276.1m

Other Expenses

CN¥19.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.074
76.54%
5.08%
27.1%
View Full Analysis

About 300238

Founded
1999
Employees
535
CEO
Feng Zhao
WebsiteView website
www.guanhaobio.com

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis. In addition, it offers artificial lens and medical instruments; and cell technology services. Its products can be used in neurosurgery, thoracic general surgery, ophthalmology, dermatology, orthopedics, cosmetology, plastic surgery, and other areas. Guanhao Biotech Co.,Ltd. was founded in 1999 and is headquartered in Guangzhou, China.

Recent 300238 News & Updates

Recent updates

No updates